Click image to zoom
Lancet Surgisphere Hydroxychloroquine Study
The webpage on the medical journal The Lancet of a now-retracted study on anti-malarial drug hydroxychloroquine as treatment for COVID-19 is seen on a mobile phone in Manila, Philippines on Wednesday, 23 September 2020. Leading medical journal The Lancet announced changes to its editorial policy after retracting a study by Surgisphere on the adverse effects of hydroxychloroquine as treatment for COVID-19 after its authors found lapses on the data gathered by the US healthcare analytics company. (Photo Illustration by Richard James Mendoza/NurPhoto)
Photo Details
| Photo ID | #6025002 |
|---|---|
| Date Taken | |
| Location | N/A |
| Photographer | Richard James Mendoza/NurPhoto |
| Category | Politics |
| Copyright | © 2026 NurPhoto - Richard James Mendoza/NurPhoto |
Related Keywords
treatment
COVID
Leading medical journal
retracted study
Lancet announced changes
adverse effects of hydroxychloroquine
anti-malarial drug hydroxychloroquine
editorial policy
data
Richard James Mendoza
Surgisphere
Photo Illustration
NurPhoto
US healthcare analytics company
mobile phone
Manila
Philippines
authors
webpage
No People
Text
Font
Rights-Managed (RM) · Single Editorial Use
License This Image
Configure usage rights. Price adjusts in real time.
One license covers one publication within the parameters you select. Each additional publication (e.g. separate articles, posts, issues) requires its own license. License terms ›
Need custom or commercial rights?
Contact Sales
· [email protected]
2026 NurPhoto. All rights reserved.
This image is the property of NurPhoto and is protected under international copyright laws.